BrainStorm Cell Therapeutics
BCLI
#10915
Rank
A$15.54 M
Marketcap
A$1.41
Share price
-4.04%
Change (1 day)
35.33%
Change (1 year)

Earnings for BrainStorm Cell Therapeutics (BCLI)

Earnings in 2026 (TTM): -A$15.47 Million

According to BrainStorm Cell Therapeutics's latest financial reports the company's current earnings are N/A. In 2025 the company made an earning of -A$15.29 Million, an increase over its 2024 earnings that were of -A$17.24 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for BrainStorm Cell Therapeutics from 2003 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -A$15.47 Million1.22%
2025 -A$15.29 Million-11.32%
2024 -A$17.24 Million-32.39%
2023 -A$25.5 Million-29.18%
2022 -A$36 Million-0.74%
2021 -A$36.27 Million-23.12%
2020 -A$47.17 Million36.8%
2019 -A$34.48 Million66.71%
2018 -A$20.69 Million181.66%
2017 -A$7.35 Million-0.6%
2016 -A$7.39 Million-41.31%
2015 -A$12.59 Million-8.22%
2014 -A$13.72 Million89.74%
2013 -A$7.23 Million42.27%
2012 -A$5.09 Million-12.45%
2011 -A$5.81 Million63.04%
2010 -A$3.56 Million35.52%
2009 -A$2.63 Million-48.99%
2008 -A$5.15 Million-44.39%
2007 -A$9.26 Million
2005 -A$4.8 Million-91.44%
2004 -A$56.02 Million94007.62%
2003 -A$0.06 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Biogen
BIIB
A$0.65 B-4,330.18%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
-A$3.76 Billion 23,973.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Seagen
SGEN
-A$1.18 Billion 7,413.55%๐Ÿ‡บ๐Ÿ‡ธ USA
Cytokinetics
CYTK
-A$1.16 Billion 7,293.01%๐Ÿ‡บ๐Ÿ‡ธ USA
Agenus
AGEN
A$0.22 B-1,535.45%๐Ÿ‡บ๐Ÿ‡ธ USA
Acceleron Pharma
XLRN
-A$0.38 Billion 2,328.14%๐Ÿ‡บ๐Ÿ‡ธ USA